Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rmhTNF HIPEC for Colorectal Cancer with Peritoneal Metastases
NCT05755685Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Feb 2023
- Primary completion
- Jan 2024
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of tasonermin in colorectal cancer (CRC), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
tasonermin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05755685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05755685.